Semin Respir Crit Care Med 2000; 21(1): 0061-0070
DOI: 10.1055/s-2000-9928
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Antibiotic Side Effects

Richard A. Gleckman1 , John S. Czachor2
  • 1St. Joseph's Hospital and Medical Center, Paterson, New Jersey
  • 2Wright State University School of Medicine, Miami Valley Hospital, Dayton, Ohio
Further Information

Publication History

Publication Date:
31 December 2000 (online)

 

ABSTRACT

There is recent enhanced interest in the potential of medication to produce serious toxicity, and the television media have focused on the serious side effects and drug-drug interactions caused by antibiotics. In fact, a recent hospital study noted that drug-related toxicity was one of the most common causes of death for hospitalized patients. Antibiotic-induced adverse events contribute to host injury diagnostic confusion and excessive medical costs. In addition, however, a ``spin-off'' of antibiotic-induced adverse events is the emergence and dissemination of drug-resistant organisms.

This chapter will describe the adverse events and drug-drug interactions produced by those antibiotics that are most commonly prescribed to patients to prevent or treat respiratory tract infections. An effort will also be made to focus on those unique settings (the patient with renal insufficiency, the patient receiving immunosuppressive medication, the pregnant patient, the elderly patient, and the HIV-infected patient who is a candidate for primary or secondary prophylaxis for Pneumocystis carinii) that require a knowledge of antibiotic-induced adverse events.

KEYWORD

Antibiotic resistance - drug-drug interactions - respiratory tract infection

REFERENCES

  • 1 Roujeau J C, Kelly J P, Naldi L. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.  N Engl J Med . 1995;  333 1600-1607
    CrossrefPubMedGoogle Scholar
  • 2 Saliba B, Herbert P N. Oxacillin hepatotoxicity in HIV-infected patients.  Ann Intern Med . 1994;  120 1048
    PubMedGoogle Scholar
  • 3 Coopman S A, Johnson R A, Platt R. Cutaneous disease and drug reactions in HIV infection.  N Engl J Med . 1993;  328 1670-1674
    CrossrefPubMedGoogle Scholar
  • 4 Lin R Y. A perspective on penicillin allergy.  Arch Intern Med . 1992;  152 930-937
    CrossrefPubMedGoogle Scholar
  • 5 Snavely S R, Hodges G R. The neurotoxicity of antibacterial agents.  Ann Intern Med . 1984;  101 92-104
    CrossrefPubMedGoogle Scholar
  • 6 Titanji R, Trofa A. Hypokalemia associated with ticarcillin-clavulanic acid.  Maryland Med J . 1993;  42 1013-1014
    PubMedGoogle Scholar
  • 7 Sattler F R, Weitekamp M R, Ballard J O. Potential for bleeding with the new beta-lactam antibiotics.  Ann Intern Med . 1986;  105 924-931
    CrossrefPubMedGoogle Scholar
  • 8 Linton A L, Clark W F, Driedger A A. Acute enterstitial nephritis due to drugs.  Ann Intern Med . 1980;  93 735-741
    PubMedGoogle Scholar
  • 9 Fass R J, Copelan E A, Brandt J T. Platelet-medicated bleeding caused by broad-spectrum penicillins.  J Infect Dis . 1987;  155 1242-1248
    CrossrefPubMedGoogle Scholar
  • 10 Heim-Duthoy K L, Caperton E M, Pollack R. Apparent biliary pseudolithiasis during ceftriaxone therapy.  Antimicrob Agents Chemother . 1990;  34 1146-1149
    PubMedGoogle Scholar
  • 11 Calandra G, Lydick E, Carrigan J. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem/cilastatin.  Am J Med . 1988;  84 911-918
    CrossrefPubMedGoogle Scholar
  • 12 Tedesco F J, Barton R W, Alpers D H. Clindamycin-associated colitis: A prospective study.  Ann Intern Med . 1974;  81 429-433
    PubMedGoogle Scholar
  • 13 Joshi N, Miller D Q. Doxycycline revisited.  Arch Intern Med . 1997;  157 1421-1428
    CrossrefPubMedGoogle Scholar
  • 14 Wallace M R, Mascolo J R, Oldfield E C. Red man syndrome: Incidence, etiology and prophylaxis.  J Infect Dis . 1991;  164 1180-1185
    CrossrefPubMedGoogle Scholar
  • 15 Appel G B. Aminoglycoside nephrotoxicity.  Am J Med . 1990;  88(suppl 3C) 16S-20S
    PubMedGoogle Scholar
  • 16 Jick H. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients.  Rev Infect Dis . 1982;  4 426-428
    CrossrefPubMedGoogle Scholar
  • 17 Hopkins S. Clinical toleration and safety of azithromycin.  Am J Med . 1991;  91(suppl A)75 40S-45S
    PubMedGoogle Scholar
  • 18 Stahlmann R, Lode H. Safety overview: Toxicity, adverse effects and drug interactions. In: Andriole VT, ed. The Quinolones San Diego: Academic Press, 1998: 369-414
    Google Scholar
  • 19 Watkins V S, Polk R E, Stotka J L. Drug interactions of macrolides: Emphasis on dirithromycin.  Ann Pharmacother . 1997;  31 349-356
    PubMedGoogle Scholar
  • 20 Anderson J A. Allergic reactions to drugs and biological agents.  JAMA . 1992;  268 2845-2858
    PubMedGoogle Scholar
  • 21 Pleasants R A, Walker T R, Samuelson W M. Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis.  Chest . 1994;  106 1124-1128
    PubMedGoogle Scholar
  • 22 Segreti J, Trenholme G M, Levin S. Antibiotic therapy in the allergic patient.  Med Clin North Am . 1995;  79 935-942
    PubMedGoogle Scholar
  • 23 Itokazu G S, Weinstein R A. Aerosolized antimicrobials: Another look.  Crit Care Med . 1998;  26 5-6
    PubMedGoogle Scholar
  • 24 Manian F A, Stone W J, Alford R H. Adverse antibiotic effects associated with renal insufficiency.  Rev Infect Dis . 1990;  12 236-249
    CrossrefPubMedGoogle Scholar
  • 25 Livornese Jr L L, Benz R L, Ingerman M J. Antibacterial agents in renal failure.  Infect Dis Clin North Am . 1995;  9 591-614
    PubMedGoogle Scholar
  • 26 Kroboth P D, McNeil M A, Kreeger A. Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysis.  Arch Intern Med . 1983;  143 1263-1265
    CrossrefPubMedGoogle Scholar
  • 27 McCormack J P, Jewesson P J. A critical re-evaluation of the ``therapeutic range'' of aminoglycosides.  Clin Infect Dis . 1992;  14 320-339
    PubMedGoogle Scholar
  • 28 Hatala R, Dinh T, Cook D J. One daily aminoglycoside dosing in immunocompetent adults: A meta-analysis.  Ann Intern Med . 1996;  124 717-725
    PubMedGoogle Scholar
  • 29 Barza M, Ioannidis J P, Cappeleri J C. Single or multiple daily doses of aminoglyccosides: A meta-analyses.  BMJ . 1996;  312 338-345
    CrossrefPubMedGoogle Scholar
  • 30 Prins J M, Weverling G J, de Blok K. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.  Antimicrob Agents Chemother . 1996;  40 2494-2499
    PubMedGoogle Scholar
  • 31 Cockcroft D W, Gault M H. Prediction of creatinine clearance from serum creatinine.  Nephron . 1976;  16 31
    Google Scholar
  • 32 Glyptis A, Sordillo E M, Kotler D P. The Cockcroft Gault (CG) equation is inaccurate for prediction of creatinine clearance (CrC1): A caution for aminoglycoside dosing.  Clin Infect Dis . 1996;  23(Abstract 297) 915
    PubMedGoogle Scholar
  • 33 Hichling K, Begg E J, Perry R E. Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients.  Crit Care Med . 1991;  19 1041-1047
    PubMedGoogle Scholar
  • 34 Sands M, Brown R B. Interactions of cyclosporine with antimicrobial agents.  Rev Infect Dis . 1989;  11 691-696
    PubMedGoogle Scholar
  • 35 Paterson D L, Singh N. Interactions between tacrolimus and antimicrobial agents.  Clin Infect Dis . 1997;  25 1430-1440
    PubMedGoogle Scholar
  • 36 Bradley P P, Warden G D, Maxwell J G. Neutropenia and thrombocytopenia in renal allograft recipients treated with trimethoprim-sulfamethoxazole.  Ann Intern Med . 1980;  93 560-562
    PubMedGoogle Scholar
  • 37 Korzeniowski O. Antibacterial agents in pregnancy.  Infect Dis Clin North Am . 1995;  9 639-651
    PubMedGoogle Scholar
  • 38 Helms S E, Bredle D L, Zajic J. Oral contraceptive failure rates and oral antibiotics.  J Am Acad Dermatol . 1997;  36 705-710
    PubMedGoogle Scholar
  • 39 Gleckman R. Antibiotic concerns in the elderly: A clinician's perspective.  Infect Dis Clin North Am . 1995;  9 575-590
    PubMedGoogle Scholar
  • 40 Millan J, Gleckman R. Selecting the right antibiotics for elderly patients.  J Crit Illness . 1997;  12 590-598
    PubMedGoogle Scholar
  • 41 Gleckman R A, Borrego F. Adverse reactions to antibiotics: Clues for recognizing, understanding, and avoiding them.  Postgrad Med . 1997;  101 97-108
    PubMedGoogle Scholar
  • 42 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: A summary. MMWR Morb Mortal Wkly Rep .  1995;  44 1-35
    PubMedGoogle Scholar
  • 43 Carr A, Penny R, Cooper D A. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.  AIDS . 1993;  7 65-711
    PubMedGoogle Scholar
      >